A dispute over whether University College Dublin is entitled to a 15% shareholding in a fast-growing company involved in developing commercial processes for global pharmaceutical giants has come before the Commercial Court.

A dispute over whether University College Dublin is entitled to a 15% shareholding in a fast-growing company involved in developing commercial processes for global pharmaceutical giants has come before the Commercial Court.

Saudi oil major Aramco has invested in former UCD campus company OxyMem, adding further to the Irish company’s growing shareholder base.